{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:17:36Z","timestamp":1792217856363,"version":"4.4.0"},"reference-count":35,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T00:00:00Z","timestamp":1241481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cytomegalovirus (CMV) infection remains as an important cause of morbidity and mortality in children undergoing hematopoietic stem cell transplantation (HSCT). Our aim was to assess the incidence, risk factors, and outcome related to CMV infection in children after HSCT in a developing country.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From October 1, 1999, to December 31, 2005, we prospectively studied all patients admitted to the HSCT unit at Hospital Luis Calvo Mackenna in Santiago, Chile. Serologic studies before transplantation and weekly CMV infection surveillance (antigenemia or quantitative PCR) were routinely obtained. Patients with positive antigenemia or quantitative PCR received pre\u2010emptive therapy with ganciclovir, and cases of unfavorable clinical evolution, persistent positive antigenemia, or quantitative PCR after 14 days of ganciclovir were treated with foscarnet.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ninety\u2010seven patients received HSCT. Their median age was 8 years (range, 3 months to 24 years) and their overall survival was 67%. CMV reactivation was diagnosed in 26 patients. Of these, three developed CMV disease (two interstitial pneumonia, one hemorrhagic cystitis). One of the patients with pneumonia died. Risk factors identified were pre\u2010transplant serologic status (positive recipient), acute and chronic graft versus host disease (GvHD), GvHD prophylaxis, and treatment with antithymocyte globulin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The rate and prognosis of CMV infection among children treated at our HSCT unit is similar to those reported from industrialized countries. These findings reflect adequate prevention and management of CMV infection within our program. Pediatr Blood Cancer 2009;53:453\u2013458. \u00a9 2009 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pbc.22060","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T16:25:58Z","timestamp":1241540758000},"page":"453-458","source":"Crossref","is-referenced-by-count":18,"title":["Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile"],"prefix":"10.1002","volume":"53","author":[{"given":"Claudia","family":"Paris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Santolaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana J.","family":"Zepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,5,5]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-2265.2004.00183.x"},{"key":"e_1_2_6_3_2","first-page":"454","volume-title":"Enfermedades infecciosas en pediatr\u00eda","author":"Cofre J","year":"2004"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2005.00370.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/08880010590935158"},{"key":"e_1_2_6_6_2","first-page":"531","article-title":"Seroprevalencia de Citomegalovirus y Toxoplasma Gondii en poblaci\u00f3n sana menor de 30 a\u00f1os en Santiago de Chile","volume":"125","author":"Abarca K","year":"1997","journal-title":"Rev M\u00e9d Chile"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(03)00287-8"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3143"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705199"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1182\/blood.V71.5.1432.1432","article-title":"Cytomegalovirus Infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation","volume":"71","author":"Wingard J","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/342883"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.3.533"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.4.1334-1338.2001"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2007.00242.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700498"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(03)00149-6"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood.V67.4.1162.1162","article-title":"Cytomegalovirus infection after bone marrow transplantation: An association with acute Graf\u2010v\u2010Host Disease","volume":"67","author":"Miller W","year":"1986","journal-title":"Blood"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20678"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-197410000-00001"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4241"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3636"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/JCM.38.11.4006-4009.2000","article-title":"Detection of cytomegalovirus DNA in human specimens by LightCycler PCR","volume":"38","author":"Schaada L","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.1999.010306.x"},{"key":"e_1_2_6_25_2","volume-title":"Software: The PHREG procedure, preliminary documentation","author":"SAS\/STAT","year":"1991"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-012864"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3616"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.16.4.647-657.2003"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj132"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2002.v8.pm12064366"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703515"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328307c7b4"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/514339"},{"key":"e_1_2_6_34_2","first-page":"898","article-title":"Maribavir (ViroPharma)","volume":"5","author":"Lu H","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2006.07.010"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2005.00397.x"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.22060","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.22060","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.22060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T17:58:10Z","timestamp":1697651890000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.22060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1002\/pbc.22060"],"URL":"https:\/\/doi.org\/10.1002\/pbc.22060","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,5]]}}}